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                         INTRODUCTION
Around 10 - 50% of all deliveries are preceded by labour induction, a proportion 
that has not varied dramatically over recent years. Fetal death was the only indication for 
labour induction centuries ago, while this is now a very rare indication, with prolonged 
pregnancy and maternal hypertensive disorders being the major indications for the last 
50–60 years. Safety, success, and patient satisfaction continue to be the major objectives 
with economic evaluations now becoming a significant factor in the search for the ideal 
induction method.                         
                 TURNBULL(1970) said that the spontaneous labour is robust and effective 
mechanism and should be allowed to operate on own. we should induce labour if we are  
sure we can do better.
                   Induction of labor is defined as the initiation of the process of labour, by 
artificial  methods  to  anticipate  delivery  via  naturalis  after  the fetus  has  attained the 
viability.
                   In modern obstetrics, induction of labour is mainly attempted when 
continuation of pregnancy may harm the mother, fetus or both. Ideally the patient to be 
induced should be close to term, in good health with adequate pelvis and favourable 
cervix  with  preferably  a  viable  fetus.  The  induction  of  labour  is  aimed  at  vaginal 
delivery of a healthy infant with risk of minimal morbidity and distress to infant and 
mother.  Induction is termed failed when the uterus fails  to contract after attempts at 
stimulation or the uterus contracts abnormally and the cervix does not dilate or the fetus 
is  in jeopardy.  The stimulation of  uterine contractions by means of pharmacological 
agents  administered  to  the  patients  by  any  route  with  the  aim  of  starting  labour 
constitutes “medical induction of labour”.  There is no single satisfactory method that 
can be used in all patients. Each patient needs to be viewed in the context of her past 
obstetrical history and complications in the pregnancy before deciding on the mode of 
termination.
Since no method of induction is free from complications, this study is undertaken 
with the aim of observing various clinical aspects and outcome of labour after induction 
by various methods in IOG, Egmore.
HISTORICAL REVIEW
                     Induction of labour has a long and interesting history. In the previous times, 
it was employed almost exclusively for the particular purpose of ensuring the birth of a 
small baby in cases of severe pelvic deformity, and thus giving the woman her only 
chance  of  producing  a  live  child.  It  was  a  method  of  treatment  peculiar  to  British 
obstetrics.
                MACAULAY performed it for the first time in 1756. He induced premature 
labour in contracted pelvis. It was performed in Britain as a definite treatment for pelvic 
malformation. In 1756, Macaulay popularized “low rupture of membranes” for induction 
of labour, which was referred to as the “English method”. Thomas Denman in 1793 also 
used the same to induce labour in contracted pelvis.
             SCHEEL in 1979 used low amniotomy – It  is  known as  “SCHEELS 
METHOD”.  It  was  first  performed  in  Britain  as  a  definite  treatment  for  pelvic 
malformation. For many years it was used only in Britain.
   In Germany WENZEL in 1809, performed it first. But in France, it met with 
religious and political opposition.
            BAUDELOCQUE objected to it very much. In 1802, HERDER studied the 
electrical stimulation of labour on cervical dilation resulting in reduction of the duration 
of  labour.  RADFORD of  Manchester  also  employed  this  method.  In  1973, 
THEOBALD also used this method for induction of labour.
              HAMILTON in 1980 introduced the stripping of membranes to induce labour.
             In 1820,  ULSAMER and  D’OUTREPONT tried massaging the uterus for 
induction. In the same year  BRUNNING HAUSEN introduced spongy tent into the 
cervix  which  caused  cervical  dilation  and  thereby  inducing  labour.  It  was  used  for 
removing the dead fetus.
           In 1839, FRIEDRICH tried nipple stimulation for induction of labour.
              In 1842, SCHOLLER as a method to induce labour, used tampons.
             In 1844, COHEN used extraamniotic injection of fluids for induction of labour, 
which is called as “COHENS METHOD”. In modern obstetrics, prostaglandin solutions 
and gels are injected extraamniotically to induce labour. In the same year  KIWISCH 
used hot vaginal douches.
            SCANZONI (1856), used hot carbolic douche. It produced sepsis and placental 
separation. So it was abandoned.
            KRAUS’S method-In 1855, Kraus used bougie to induce labour. But it produced 
severe degree of infection. So it was later replaced by low rupture of membranes.
            BARNES in 1861, introduced rubber bag filled with water for induction. This 
was used by JAMES 100 years earlier.
          In 1865, WILSON used laminaria, tent for induction of labour. Laminaria tents 
have been used for more than 100 years in Germany and Japan.
               In 1878 CROSS and PITKIN used laminaria tent for induction. It helped only 
in increasing the Bishop’s score and had no action on the myometrium. Low amniotomy 
again became popular in 1930 by DREW SMITH.
              The oxytocic effect of posterior pituitary extract was first noticed by DALE, in 
1906, but the credit of introducing the drug into the clinical practice goes to BLAIR 
BELL (1909) who employed it in the treatment of postpartum hemorrhage and uterine 
atony.
            HOFBAUER (1911) suggested its use in the treatment of uterine inertia and two 
years later WATSON (1913) advocated its routine use in the induction of labour.
           In 1920, B.P.WATSON used quinine for induction of labour. But because of 
unpredictable results and possible danger to the fetus, this method has been discarded in 
general.
          It was not until 1929 that KAMM et al separated and concentrated two active 
principles in the form of potent solid preparations, “Itocin” and “Pitressin”.
                KLEIN (1939) used spartine sulphate of labour. Intrauterine injection of 
hypertonic  glucose  was  used  for  induction  of  labour  by  ABUREK  in  1939,  in 
intrauterine death or malformed fetus. Painless labour has been the cherished desire of 
every woman and the constant aim of the obstetrician.
              THEOBALD (1948) first advocated one unit of oxytocin to 500 ml of Dextran 
in aqua infused in at a rate of 40 drops per minute, as the extreme range of physiological 
oxytocin dose.
In  1954, CUNNIGHAM in  Sydney  did  daily  digital  dilation  of  Cervix,  if  it 
admitted two fingers. This helped in sweeping of membranes, prior to low amniotomy.
ULIRICH (1956)  reported  valethamate  bromide  as  a  potent,  rapidly  acting 
cholinolytic, spasmolytic, musculotropic agent.
DILLEN et  al (1960)  –  reported  the  use  of  buccal  pitocin  to  induce  labour. 
Buccal tablets are used for both induction and augmentation.
NADRARNI and SHAH (1964) used unitocin for acceleration of labour.
MITRA et al (1978) found valethamate bromide to be effective in both primi and 
multi and showed that it shortened the duration of labour remarkably with no untoward 
effect on both mother and fetus.
The  term  “Prostaglandin”  was  introduced  by VANULER  in  1935.  in  1971, 
KARIM and SHARMA first reported the results of clinical trail of induction of labour 
at term with the use of oral PGE2.  They successfully induced labour in 79 of the 80 
patients.  Since  that  time,  a  large  number  of  reports  have  appeared  in  the  literature, 
evaluating the efficacy of oral PGE2 for induction of labour with the success rate of 
more than 85%.
               ALDER and EMBERY (1975)  have  used  PGE2 extraamniotically. 
MELLOWS et al (1977), WILSON (1978) have given PGE2 intravaginally. EMBREY et al 
(1980), HEFNI and LEWIS (1980), has given PGE2 intracervically.
PEARLE at al (1979), VERMA et al (1981) found that PGE2 pessaries were easy to 
place in the posterior vaginal fornix and were useful in inducing labour.
          LIGGINS and his coworkers in 1968 said that, cortisone secreted by the fetal 
adrenals is the key factor in the initiation of labour and also for the maturation of fetal 
lungs.
          MATI et al (1973) and IAN CRAFT (1976) studied the effects of betamethasone 
given by different routes, namely intraamniotic, intramuscular and intravenous to induce 
labour.
         PHYSIOLOGICAL BACKGROUND
            The cervix is essential in maintaining uterine stability during pregnancy. To 
achieve  this,  the  maintenance  of  cervical  shape and  consistency  is  imperative  since 
cervical ‘ripening’ is a physiological process occurring throughout the latter weeks of 
pregnancy and is completed with the onset of labour. When delivery is necessary and 
ripening has not had time to occur, or has failed to be initiated, this natural process has to 
be accelerated. 
                    The cervix possesses a unique construction as described by Danforth (1947) 1 
to enable it to perform its various roles. It consists predominantly of a stromatous body 
of connective tissue that can be subdivided into a superficial loose zone and a deeper 
dense stromal zone. The main elements of this connective tissue are collagen together 
with a small amount of elastic tissue and an even smaller component of muscle fibres. 
The  collagen  is  composed  of  dense  regular fibrils  arranged in  parallel  bundles  held 
together by cross-links, with a few interspersed mast cells and other cellular elements. 
The  ground  substance  is  composed  of  proteoglycan  complexes  consisting of 
glycosaminoglycan side  chains (GAGs)  on core proteins linked to  a  hyaluronic  acid 
chain that bind tightly. The dominant GAGs in the cervix are dermatan sulphate and 
chondroitin  sulphate, both  of  which  contain  hyaluronic  acid  conferring  additional 
binding  strength  and  have  hydrophilic  properties.  Fibroblasts with  numerous  long 
cytoplasmic  processes  radiating  from  one cell  body  to  another,  possibly  similar  to 
myometrial gap junctions, infiltrate the ground substance (Ulmsten 1986)2                    
                 With the advance  of pregnancy, increased vascularity is seen and the 
fibroblasts become secretory, white cells and macrophages migrate out of vessel walls 
into  the  cervical  stroma  with  an  increase  in  water content.  There  is  a  reduction  in 
collagen content and a relative increase in the glucuronic acid-containing GAG heparin 
sulphate that  binds  much  less  strongly  (Uldbjerg   et  al.   1983 )4 Ekman   et  al.   1986 )3 . 
Enzymatic  breakdown  of  collagen  fibrils  by  collagenases/matrix metalloproteinases 
produced by fibroblasts and polymorphonuclear leukocytes alongside leukocyte elastase, 
which catabolises elastin, leads to increased cervical compliance. The precise mediation 
and inter-relationships remain to be elucidated, but the prostaglandins and their synthase 
inhibitors  are  closely  implicated  with  the known  increase  observed  as  pregnancy 
advances. Significantly there is reasonably strong evidence that the process of cervical 
ripening will occur without any detectable uterine contractions being stimulated (Ledger 
et al.   1985 ,  Forman  et a  l.   1992 )4 Platelet activating factor (PAF) (Sugano et al )  5  and 
monocyte chemotactic protein-1 (MCP-1) (Yamamoto  et al  .  2000 ) have been proposed as 
possible interactants in the remodeling process involved in cervical ripening, as has nitric 
oxide,  synthesized  by  macrophages,  myometrium and the  cervix  (Chwalisz  &  Garfield 
1998).6                               
INDUCTION OF LABOUR
                INDUCTION OF LABOUR is
1. Absolute if risk of continuing pregnancy is life threatening
2. Relative if not life threatening but need intervention
3. Hospital protocol applicable in cases like post dated pregnancy and Rh –ve 
pregnancies
4. Social induction 
Medical Indications for the Induction of Labor  7,8,9
Postdated pregnancy
Premature rupture of the membranes*
Hypertension or preeclampsia or eclampsia
Chorioamnionitis
Severe intrauterine fetal growth retardation
Significant maternal medical problems, such as diabetes mellitus with pregnancy at term
   *No labor within four hours after membranes have ruptured.
Contraindications to the induction of labor:
 
 Cephalopelvic disproportion because of malpresentation or abnormal pelvic bone 
structure 
 Hypersensitivity to cervical ripening agents 
 Major degree of Placenta  praevia 
 Vasa praevia 
 Previous classical uterine incision or incision because of metroplasty or extensive 
myomectomy when the cavity is opened 
 Active genital Herpes infection 
 Invasive cervical carcinoma 
 Transverse lie 
Conditions where Induction of labour is not a true contraindication but 
where special caution is required 
 Multiple pregnancy 
 Polyhydramnios 
 Severe hypertension. 
 Breech presentation 
 One or more previous cesarean section 
 Abnormal fetal heart rate not requiring emergency cesarean section 
 Maternal heart disease. 
Risks of Induction  of  labour
Maternal Risks                                   
 Failure leading to Cesarean section 
 Increased risk of operative vaginal delivery 
 Increased risk of post partum hemorrhage 
 Uterine hyper stimulation
 Rupture uterus 
 Intrauterine infection, Chorioamnionitis 
 Amniotic Fluid Embolism 
 Precipitate labor , Dysfunctional labor 
 Abruptio Placenta 
 APH from undiagnosed placenta praevia 
 Water intoxication 
 Fetal Risks 
 Fetal distress  
 Fetal death 
 Neonatal sepsis 
 Iatrogenic delivery of a preterm infant 
 Cord prolapse 
 Neonatal jaundice
 Increased risk of birth trauma
PREINDUCTION CERVICAL ASSESSMENT:
              It is known that success of labor induction is closely related to ripeness of the 
cervix. Various scores have been proposed to evaluate the cervical status. 
 a)  Bishop’s Score: This was proposed by Bishop in 1964  (10) and is the most widely 
used  score.  It  was  originally  proposed  to  determine  the  suitability  of  a  patient  for 
Induction  of  labour  in  patients  who  were  parous,  at  term,  had  an  uncomplicated 
pregnancy and the fetus was in cephalic presentation.
                    Bishop’s Score
 
Factor                      0                      1                             2                         3
 
Dilatation (cm)       0                    1-2                           3-4                       5-6
Effacement (%) 0-30                 40-50                      60-70                         80
Station               - 3                    - 2                           -1 or 0                +1 or +2
Consistency        Firm                 Medium                  Soft                         -
Position               Posterior           Mid                        Anterior                  -
 
Cm = Centimeters
 * A score of 9 or more ensured a safe and uniformly successful induction 
 
 
                 Fields 11 a year earlier to Bishop had in addition to scoring the physical 
characteristics  of  the  cervix  also  considered  other  factors.  His  proposed  score  is  as 
follows.
  Fields System for Rating Readiness for Induction
0 1 2
Timing  of 
induction 
Versus  EDC# 
(wks)        
Uncertain or
>3 prior
1-3     prior within 1week
Attitude Objects|/ fears Hesitates/accepts Enthusiastic
Estimated 
fetal weight 
             (grams) 
< 2,500 Uncertain > 2,500
Uterine  tone  on 
palpation  
Flaccid Some tone Firm
Softness  of 
cervix               
Firm Firm 
Somewhat soft
Soft
Effacement(%) < 80 80 > 80
Position of cervix Posterior 450 to vaginal 
axis
Toward Vulva
Station  of 
presenting 
part (cm) 
  
-2 or higher -1 to 0 + 1 or lower
Dilation (cm) 0-1 2-3 >3
vaginal discharge No change Increased Blood tinged
 
 # EDC : Expected date of confinement
* Induction with a score of 16 more is considered favorable 
                Burnett later on modified the original Bishop’s score giving a maximum score 
of  2  to  each  of  Bishop's  five  categories,  giving  a  total  maximum score  of  10.  He 
considered effacement in terms of length and not percentage and considered previous 
term birth and cephalic presentation to be pre-requisites for induction. 
 
Table 4. Burnett’s  Modification of the Bishop Score.12
Factor                                      0                      1                      2
 
Dilatation (cm)                < 1.5                    1.5 – 3                 > 3
Station                            -2 or higher            - 1                      0 or lower
Position                            Posterior              Mid                     Anterior
Effacement (cm)             1.5 or more          Intermediate        0.5 or less
Consistency                     Firm                     Intermediate           Soft
 
 
Cm = centimeters 
* Outcome of patients with a score of less than 6 was unfavorable, with a score of 9- 10 
all   patients could be delivered within 4 hours and most within 24 hours. 
 
 
            Evaluating the performance of Bishop's score, Lange et al (6) observed that 
cervical  dilatation  was  twice  as  important  as  the  other  factors  and  proposed  a 
modification of the original score which predicted successful induction equally well. 
  Pelvic Score Proposed by Lange et al 13
Factor                            0                  1                2              3       Multiply by
 
Dilatation (cm)             0                1-2            3-4               >4              X 2     
Length (cm)                  3                 2               1                  0               X 1
Station(cm)                 -3               - 2             -1 or 0        +1 or +2        X 1   
 
 
                   O'Leary and Ferrell 14 in 1987 had proposed a semi- quantitative 
ultrasound scoring system on Transabdominal Ultrasound evaluating the thickness and 
contour of the lower uterine segment, length and dilatation of the cervix and the station 
of the presenting part. Later Transvaginal ultrasound was used by Boozarjomehri et al15 
in 1994 who found that cervical length measurement was significantly associated with 
the duration of the latent phase of labor. Importantly wedging if present was associated 
with  a  shorter  duration  of  both  the  latent  phase  and  the  total  duration  of  labour. 
However, a regression analysis of the ultrasound assessment by other authors has noted 
that  cervical  length  assessment  by  ultrasound  did  not  provide  significant  additional 
information; only cervical dilatation was predictive of the duration of the latent phase 
PHARMACOLOGICAL METHODS
OXYTOCIN
              Oxytocin is a polypeptide hormone secreted from the posterior pituitary gland 
which acts as a potent uterotonic agent. The drug was used intravenously in 1948 by 
Theobald et al to induce labor. Later in 1958      Du Vigneaud et al synthesized the drug. 
Since du Vigneaud synthesized Syntocinon from the oxytocin in the 1950s (den Hertog  et   
al.   2001 )16 it has been used by intravenous infusion for the majority of women having 
their labour induced. Although still used as the primary induction agent occasionally, it 
is more frequently given to assist the induction process using prostaglandins when the 
cervix is unfavourable or as an adjunct to low amniotomy in more favourable cases. 
          Protocols using intravenous infusions of oxytocin that are used these days are 
largely based on the work of Turnbull and Anderson (1968).17,18  Although originally given as a 
constant low dose infusion at less than 10 mU/min, this has been replaced by titrated 
doses, determined  by  the  intensity  and  frequency  of  uterine  contractions assessed 
clinically by staff adjusting the infusion rate using mechanical pumps or electronic drip 
counters.                  
            Alternatively, automatic infusion pumps governed by intrauterine contraction 
pressures using solid-state pressure transducers have been used providing an automatic 
increase or decrease in rate with the theoretical avoidance of over dosage (Francis   et al   
1970). These are usually set at a starting rate around 1–4 mU/min and increase variably 
(Lamont  et al   1991  )19                                                                   arithmetically (Kurup et al 
1991)20  or logarithmically (Toaff   et al   1978 )  21          at 15–30 min intervals often to a 
maximum  of  around  32  mU/min,  or  until  satisfactory labour  has  been  established; 
occasionally higher rates may be required. 
                  There is evidence that continuous intravenous infusions  of oxytocin to induce 
or augment labour down regulate myometrial oxytocin receptors (Phaneuf  et al   2000 ) the 
clinical  consequence of this,  however,  is  uncertain.  While a pulsed administration of 
oxytocin has been tried to reduce the risk of over dosage (Pavlou et al.),  this approach 
has not been widely adopted. Most consider that the rate required to establish labour 
should be maintained into the second stage, and increased once the third stage of labour 
is  reached,  being maintained  for  approximately  an  hour  following  delivery  of  the 
placenta and membranes.
Routes of administration
Oxytocin can be administered by any parenteral route, intravenous route being the most 
widely used. It can be absorbed from the nasal or buccal mucosa, however when given 
orally it is rapidly inactivated by trypsin. 
Pharmacokinetics and mechanism of action
               The half life of oxytocin is 3-5 minutes. Once absorbed it is distributed in the 
extracellular fluid and does not bind to plasma proteins and is excreted by the liver and 
kidneys.
               The action is mediated by oxytocin receptors (OTR) which are present on the 
myometrium.  Myometrial response to oxytocin begins at 20 weeks, increases through 
out pregnancy and peaks just before initiation of labour. The response  varies according 
to  the status of  the cervix,  uterine  sensitivity,  variability  in  oxytocin clearance  rate, 
duration  of  pregnancy  and  the  pre-existing  myometrial  contractions.  The  OTR 
concentration is the rate limiting step for oxytocin action. Oxytocin on binding to the 
OTR  increases  the  intracellular  concentration  of  calcium  causing  myometrial  cell 
contraction.  Uterine  contractions  are  also  stimulated  by  a  calcium  independent 
mechanism involving the prostaglandins. PGE and PGF are increased during oxytocin 
administration. It has been postulated that Prostaglandin release by oxytocin is necessary 
for fully efficient uterine contractions during labor. 
 
Dosing and Usage Guidelines
          10 –20 units are dissolved in 1000 ml of balanced salt solution            (Ringer 
Lactate solution or Normal saline) making it as 10-20 mu/ml and it is preferable to give 
it through an infusion pump.  Further increments are made according to the low dose or 
high dose protocol given below 22 .
 Regimen                Starting dose           Incremental dose       Dosage interval
         (mU/ min)                 (mU/ min)                             ( min)  
            
Low Dose               0.5 – 1                           1                                          30-40
                                  1 –2                            2                                           15
High dose                  6                                6                                          15
                                   6                                6, 3*, 1*                              20-40  
         *  The  incremental  increase  is  reduced to  3  mU/min in  presence  of  hyper 
stimulation and reduced to 1mU/min with recurrent hyper stimulation. 
         After intravenous infusion , uterine response occurs within 3-5 minutes and  a 
steady state plasma concentration is reached in about 40 minutes. The end point to be 
achieved is  uterine contractions every 2-  3 minutes lasting for  60-90 seconds and a 
uterine pressure of 50- 60 mm Hg or 150 Montevideo units.
 
Risks of Oxytocin
        Hyper stimulation, with or without fetal heart rate changes
        Failed induction with need for repeat induction or possibly cesarean
   Increased risk for uterine rupture in some studies
   Hypotension if administered by IV bolus
        Hyponatremia if administered with large amounts of sodium poor fluids
   Antidiuretic hormone like effect if administered at high doses
        Increased risk for neonatal hyperbilirubinemia
RCOG Guidelines: (23)
     1) Oxytocin should not be started for 6 hours following administration of        
         Vaginal prostaglandins
     2) In women with intact membranes, if feasible amniotomy should be      
    Performed prior to commencement of oxytocin infusion
     3) Minimum possible dose of oxytocin should be used and titrated   
         against uterine contractions. Maximum licensed dose is 20 mU/min           
         and should not exceed 32 mU/min
       
               Randomized controlled trials have shown a wide range of dosages and 
frequencies to be successful. Dose increment schedules as short as 15 minutes and 30 
minutes have been compared, using a starting dose of 2.5 mU/minute with increases of 
the same amount, showing no significant difference between the two groups24.Successful 
low dose  protocols  have  begun  with  an  initial  dose  as  low as  0.5  mU/minute  and 
intervals as long as 60 minutes between dose increases.  Both the 20 and 40 minute 
dosage  intervals  have  been  shown  to  be  safe  and  efficient  when  using  high  dose 
oxytocin defined as a starting dose of 6 mU/minute with increases of 6 mU/minute.25 
                                                         
             Comparison of low-dose to high-dose regimes of oxytocin in metaanalysis study 
found that the potential shortening of induction to birth time with the high-dose protocol 
occurred at the expense of higher rates of excessive uterine activity, fewer spontaneous 
vaginal  deliveries,  a  trend  towards  a  higher  cesarean  section  rate  and  an  increased 
potential for  maternal morbidity.26 Hourvitz et al (1996) was the only study that focused 
on comparing different start   infusion rates: high-dose patient started at 2.5 mU/min 
versus low-dose patients   started at 1.25 mU/min.                          
                   
          No statistically significant differences between the two protocols were observed in 
induction-delivery interval and rates of c-section, abnormal  FHR or hyper stimulation. 
However, because the proportion of patients with hyper stimulation was 10% higher and 
abnormal FHR was 13% higher in the high-dose  group, they recommend the low-dose 
protocol  .  Orhue 27 included only primigravid patients and observed in the 15-minute 
protocol that while the induction-delivery interval was significantly shorter, the hyper 
stimulation rate  was more than 5 times greater  (3% vs.  16%, p=0.03)  and the fetal 
distress rate (abnormal  FHR) was almost 4 times greater (3% vs. 11%, p =0.05).Chua28 
did  not  find  any  statistically  significant  differences  in  any  of  these  outcomes  but 
nevertheless concluded   that a 30-minute interval was safer. 
PROSTAGLANDINS 
             PG E2 gel has been widely used for pre-induction cervical ripening. Local 
application of PGE2 causes cervical ripening by three mechanisms.
 Alteration of extracellular ground substance of cervix by increasing collagenase, 
elastase, glycosaminoglycans, dermatan sulfate, and hyaluronic acid  levels 
 Relaxation of smooth muscle of cervix 
 Gap junction formation leading to initiation of uterine contractions 
Preparations available, Dosage and Usage Guidelines 
 Intracervical PGE2 gel (Cervigel, Dinoripe, Prepidil) 
 Contains 0.5 mg of PGE2 
  The gel is brought to room temperature before use and  instilled in the cervical 
canal below the internal os 
 The patient lies supine for 15-30 minutes after the insertion. 
 If no response occurs in one application, a repeat insertion may be required after 6 
hours 
 Maximum of 1.5 mg or three insertions are allowed over a period of 24 hours. 
 If required oxytocin is used only after 6- 12 hours of the last insertion. 
 Intravaginal PGE2 gel 
 Vaginal PG E2 gel     contains 2.5 mg PGE2  
                                        2 doses 6 hours apart are used.
 Vaginal controlled release insert  (Cervidil ) 
  10 mg insert which releases 0.3 mg / hr of the prostaglandin 
  No need to prewarm the insert.
 The patient should lie supine for 2 hours following the insertion
 The insert is to be removed after 12 hours or when active labor 
begins or in case of hyper stimulation.
Contraindications 
Established  uterine  activity,  glaucoma,  asthma,  severe  hepatic  or  renal  impairment, 
known hypersensitivity to prostaglandins, active vaginal bleeding.
 ACOG Guidelines: 22
       Bishop’s score should be less than four. Drug should be administered near the 
delivery suite. Patient should lie recumbent for 30 minutes after the instillation. FHR 
and  uterine  activity  should  be  monitored  for  30  minutes  to  two  hours  after  the 
instillation. After this, patient may be transferred elsewhere, if there is no increase in 
uterine activity and FHR is normal. The controlled release insert should be removed at 
the onset of labor. Oxytocin should be avoided for initial 6-12 hours
 
 RCOG Guidelines: 23
      Intravaginal PGE2 should be used in preference to intracervical preparations as they 
are equally effective and administration of intravaginal PGE 2 is less invasive of the 
vaginal preparations. Tablets should be preferred over the gel as they are cheaper and 
equally effective. 
           Intravaginal or intracervical administration of exogenous PGE2 (dinoprostone) is 
the most widely used pharmacologic method to promote cervical ripening and labour 
induction 29.Prostaglandins were first used  intravenously in the late 1960-s but this route 
of   administration  was  associated  with  significant  side  effects.30A  meta  analysis 
comparing  women  who  received  prostaglandins  to  placebo  or  no  treatment  groups 
indicated that receiving prostaglandins did more to improve the cervical score and ripen 
the cervix..31Cochrane reviewers studied the use of prostaglandins for cervical ripening 
on  labour  induction  and  concluded  that  compared  with  placebo,  use  of  vaginal 
prostaglandins increased the likelihood that a vaginal delivery would occur within 24 
hours32 .                                                                                                              
         The optimum route (endocervical or vaginal), the initial dose of PGE2 and the 
interval and frequency of dosage increase is a source of great debate. A study by Seeras 
etal33 suggests that a 2 mg dose of vaginal PGE2 given on a 12 hourly basis may be as 
good or better than on a 6 hourly basis. The authors also suggest that there is little or no 
benefit  in  using  more  than  three doses.  The  American  College  of  Obstetricians  and 
Gynecologists recommend that regardless of route of administration, fetal and maternal 
well-being should be monitored for 30 to 120 minutes following administration of PGE2 
34.                                                            
               A meta-analysis suggests that when labour must be induced with an unripe 
cervix,  prostaglandins  can  decrease  the  likelihood  of  failed  induction,  decrease  the 
incidence  of  prolonged  labour  and  increase  the chance   of   spontaneous  vaginal 
delivery.
                Oxytocin is less effective than prostaglandin to help bring on labour but is as 
effective when used alone in women with ruptured membranes.  The review of trials 
found that using PGE2, inserted either via the vagina or cervix, rather than oxytocin was 
probably more effective. However, oxytocin alone compared to PGE2 used either way, 
in women with ruptured membranes, showed that all three methods are probably equally 
effective.35
                                  MECHANICAL MODALITIES
    Hygroscopic dilators :  These are natural or synthetic rods inserted through the cervical 
os and left in situ for a particular time wherein because of their osmotic properties they 
absorb endocervical and local tissue fluids . This swelling causes a controlled dilatation 
of the cervix along with releasing prostaglandins. Natural dilators are obtained from the 
seaweed Laminaria japonicum. 
     Balloon  devices:  Foley’s catheter  or  designer  balloon  devices  when  inserted 
intracervically can facilitate cervical ripening. Once properly placed (beyond the internal 
os) balloon or the catheter is inflated with 30-50 ml saline. It is recommended to either 
attach a defined weight to the catheter end ( 1litre of i.v. fliud ) or to use “gentle tugs” – 
2 to  4 each hour until the catheter or the balloon passes  out (26,27) .  Some recommend 
infusion of extra-amniotic saline at the rate of 1 cc/minute. 
NATURAL AND COMPLEMENTARY MEDICINE
                                         METHODS   
                                                                                               
                 Homoeopathy has been used in recent years for labour induction but a recent 
literature review identified only one prospective controlled trial examining the use of the 
herb ‘caulophyllum’ in a small group of women and concluded there was insufficient 
information  to draw any conclusion at present (Smith 2001),36although there have been 
concerns expressed about neonatal  morbidity resulting from its use (Finkel  & Zarlengo 
2004)37.
             Breast stimulation has been suggested as an effective inexpensive non-medical 
means of inducing labour. A Cochrane Database review of six randomized controlled 
trials involving 719 women reported a significant reduction in the number of women 
with a favourable cervix not in labour   72 h following the start of nipple stimulation 
compared  with  no  intervention.  There  was,  however,  no  reduction in  the  need  for 
delivery by caesarean section (Kavanagh  et al.   2001 b  ). 38 
          Acupuncture, however, although it has been used for the induction of labour and 
appears safe without any recognized teratogenic effects, there is very limited information 
upon its clinical effectiveness for this purpose (Smith & Crowther 2001)39. 
          
            Sexual intercourse during the latter weeks of pregnancy has been suggested as a 
logical  strategy to encourage labour  since semen is  presumed to contain the highest 
prostaglandin concentration of any body fluid. However, any role that sexual intercourse 
may have in the initiation of labour is uncertain since it could be due to the physical 
stimulation of the lower uterine segment, or endogenous release of oxytocin as a result 
of  orgasm or  the Ferguson reflex  or  from the  direct  action  of  the  prostaglandins in 
semen. A review of the relevant literature on this subject led the reviewers to conclude 
that  it  must  be difficult  to standardize sexual  intercourse as an intervention to allow 
meaningful  comparisons with  other  methods  of  induction  of  labour  particularly  for 
randomized studies involving a no-treatment or placebo group; trial violations could be 
difficult to identify (Kavanagh  et al.   2001 a  . ) 40.                    
                                        
                              
SURGICAL METHODS
Membrane sweeping and amniotomy
          Cervical  stretching  and  membrane  sweeping  performed during  a  vaginal 
examination has been shown to result in established labour in  70% of cases if repeated 
daily over three days (Swann  1958).41Amniotomy,a procedure involving puncturing the 
membranes and releasing the amniotic fluid contained beneath the presenting fetal part 
is  done  when the  cervix  is  favourable.  The manipulation  of  the  cervix   during  the 
amniotomy provokes a release of oxytocin from the posterior pituitary via the Ferguson 
reflex and this is followed a few minutes later by a release of prostaglandins into the 
uterine vein, encouraging uterine contractility (Turnbull & Anderson 1978). 
In less favourable cases, the amniotomy is usually followed after an hour or two 
with  the  addition  of  an  infusion  of  Syntocinon,  while  in  the unfavourable  case  an 
amniotomy  is  usually  performed  after  previously administered  prostaglandins  have 
provoked cervical ripening .The Cochrane reviewers concluded that stripping when used 
as an adjunct does seem to be associated with a lower mean dose of oxytocin needed and 
an increased rate of normal vaginal deliveries.42     
          Only two well-controlled trials studied the use of amniotomy alone, and the 
evidence did not support its use for induction of labor.43 
     Predicting the success of labour induction
 Cervical condition exerts a significant influence upon induced labour outcome 
and in consequence the decision about how to induce labour must take account of the 
favourability of the cervix. To assist the obstetrician in deciding which way to induce 
labour a cervical scoring system is often used. More than 12 different pelvic or cervical 
scoring schemes have been described during the past 70 years, but the semi-quantitative 
clinical scoring system described by Bishop is the one most widely employed (Bishop 
1964)10. There was no difference in success of induction as measured by induction-to-
delivery interval or by rate of vaginal,  delivery using higher initial concentrations of 
oxytocin. Higher pre-induction Bishop scores were associated with shorter labors and 
more vaginal deliveries 44                                    
           There  is  no evidence  to  support  cervical  ripening independent  of  labour 
induction. Therefore, when indicated, cervical ripening should be considered part of the 
labour induction process45. Recent reports have confirmed early studies that emphasized 
that the state of the cervix was the most important predictor of success, leaving little 
doubt that ripening of the cervix greatly facilitates labour and increases the likelihood of 
vaginal  delivery.46-48
        Fetal  fibronectin  (FFN) concentrations  in  cervical  transudate represent  a 
laboratory approach and have been shown to correlate with induced labour outcome with 
concentrations greater than 50 µg/ml associated with a favourable cervix and reduced 
intrapartum morbidity (Ekman  et al.   1995 ).49                                  A review of eight 
reports concluded that a positive FFN was associated with significantly shorter delivery 
intervals  than  when a  negative  FFN result  is obtained (Kiss   et  al.   2000 .)50Since  this 
assessment can be performed at the bedside, and there is evidence of circadian changes 
in uterine activity and responses to prostaglandins (Haluska  et al.   1987 , MacKenzie 1987), 
an assessment of FFN might assist in determining the most appropriate time during the 
working day when to initiate an induction. 
          Ultrasound assessment of the cervix has been investigated as a way of predicting 
the likely outcome of induced labour as an alternative to clinical digital examination. 
Studies have explored possible relationships between cervical length, internal cervical os 
shape and assessment of the angle between the cervical axis and the wall of the inferior 
segment of the uterus (Chandra  et al.   2001 , Pandis  et al.   2001 ).51 The results from many 
published studies, some prospectively stringently controlled and others observational, 
suggest that, as with clinical observations, there is quite wide variation in the predictive 
value.
Electrical impedance measurements across the surface of the cervix using a 8 
mm tetra  polar  pencil  probe have been used to investigate  correlations with clinical 
examination  to  assess cervical  favourability  (O’Connell   et  al.   2003 )52.A  statistically 
significant association was found with the resistivity and the favourability of the cervix.  
Serum  nitrite/nitrate  levels have  also  been  assayed  in  nullipara undergoing 
prostaglandin induction of labour and using multiple regression analyses significantly 
lower levels of each were found in women who delivered within 15 h of labour induction 
compared with those delivering over a longer period (Facchinetti  et al.   1998 )53. 
          In the study that was conducted by Nancy ,in 365 cases (in nullipara and multipara 
women),it was found out that Bishop score is a weak clinical indicator in the prediction 
of successful  vaginal  delivery induction regardless of number of birth. In  the study 
conducted by Nicolaides54 in 2001 in 240 cases between 37-42 weeks in which they used 
Dinoprostone  gel  and  oxytocin  for  induction,  cervix  length  and  Bishop  score  was 
compared.  Cesarean section was found as 19.2%, while  the rate  of  vaginal  delivery 
within 24 hours was approximately 60%. 74.3% of vaginal deliveries within 24 hours 
were multipara, and induction-birth interval was significantly found shorter in multipara. 
Bishop  score  was  found  relevant  to  successful  vaginal  delivery  and  induction-birth 
interval.  Cervix  parameter  was  indicated  to  have  a  more  powerful  prediction 
performance in terms of these parameters. 
          In the successful study conducted by Paterson-Brown 55,in 50 pregnant women, 
successful vaginal delivery and Bishop score was found clearly in relation, however, its 
prediction performance was insufficient.  Besides,  cervical  length was shown not   to 
have relation with Bishop score and induction-birth interval .  
                                     
AIM OF THE STUDY
1. To study the profile of induced labour  in a tertiary care  institution 
2. Outcome of such induction in NULLIPARA & MULTIPARA.
3. Intrapartum,  Postpartum  maternal  and  neonatal  morbidity  and  mortality  of 
patients who underwent induction of labour.  
          
MATERIALS AND METHODS
TYPE OF STUDY
         Prospective observational study.
PERIOD OF STUDY
            JANUARY 2008 TO JUNE 2008
SETTING
This study was conducted at Institute of Obstetrics and  Gynaecology, Chennai. 
Approval of institutional ethical committee had been obtained.
METHODOLOGY
SUBJECT SELECTION CRITERIA
 Inclusion Criteria
Singleton live Pregnancies
Cephalic Presentation
Gestational Age >37 Weeks
Bishop Score <4
Reactive CTG
No Spontaneous uterine contraction
Exclusion criteria
Multiple Pregnancies
Mal presentation
Preterm Pregnancies
Non Reactive CTG
Antepartum haemorrhage
Previous uterine scar
Spontaneous Labour
Reason for Induction:
     1. Absolute Indication:
As in severe PET, imminent eclampsia, eclampsia
      2. Marginal indication:
GDM on insulin, PET, Repeated false labour, AFI < 8, BOH,
Hospital  protocol  as  in  postdated  pregnancy,  Rh  negative  pregnancy  and 
prelabour rupture of membranes.
Patients were counseled regarding the decision taken and their wishes respected. 
Informed written consent obtained. 
Admission procedure
         On admission, complaints and detailed obstetric, past and personal history of the 
patient  was  obtained.  General  examination  done  and  pulse  rate,  blood  pressure, 
temperature noted.  Per  abdomen examination of  the patient  with detailed pervaginal 
examination done and Bishop score calculated. Antenatal risk factors and reason for 
induction  of  labour  was  documented.  Modified  biophysical  scoring  including 
Cardiotocogram  and  AFI  was  done.  According  to  ACOG  criteria  1999,  period  of 
gestation was confirmed.
Procedure
For   patients  with Bishop score <4 and intact  membranes,  PGE2 0.5mg was 
applied  intracervically  under  strict  aseptic  precautions  after  excluding  the 
contraindication  criterias.  Patient  reassessed  after  6  to  12 hours.  If  in  active  labour, 
active labour management by amniotomy and augmentation with oxytocin done. Labour 
monitored with partogram. Otherwise, repeat cardiotocogram done. If reactive, second 
dose of PGE2 applied in patients with intact membranes, otherwise oxytocin was used. 
In patients presenting with ruptured membranes, only oxytocin was used.
Mode of application of PGE2
Patient was advised to empty the bladder. Fetal heart rate was recorded.Then the 
patient was put in lithotomy position. Under strict aseptic precautions, a preloaded insert 
with 0.5mg of PGE2 gel was introduced into the endocervical canal and PGE2 instilled 
taking care not to rupture the membranes. Fetal heart rate was recorded again. Patient 
was made to rest in lateral position for 30 minutes. Fetal heart rate and uterine activity 
monitored for 30 minutes and further for a period of 6 hours.
Mode of oxytocin use
5units  of  oxytocin  is  added  in  500ml  of  normal  saline  and  intravenously 
administered at the rate of 5mu/min. Uterine contractions are monitored and oxytocin 
dosage increased at the same increments once in every 30mins.
Side effects
   Fever
   Vomiting and diarrhea
   Meconium staining
   Uterine hyper stimulation
   Fetal heart rate abnormalities
   Hypotension
   Water intoxication
   Cord prolapse
   Abruption
   Uterine rupture
   Postpartum haemorrhage.
   Amniotic fluid embolism
Indications for operative delivery
 Failed induction: No improvement in   Bishop score   with one application  of 
PGE2 with associated  antenatal risk factor or  cervix remains unfavourable   even after 
2 doses of PGE2  or   after adequate oxytocin stimulation.
 Fetal distress: Meconium stained liquor in early labour
Persistent late/variable deceleration on cardiotocogram.
 Arrest of cervical dilatation 
 Arrest of fetal descent.
Indications for instrumental delivery
  Prolonged second stage
  Early deceleration due to head compression in late second stage
  Maternal exhaustion
  Indicated forceps as in maternal heart disease.
Neonatal observations
   Birth weight
   APGAR
   Resuscitation
   NICU admission
   Fever
   Hyperbilirubinemia
RESULTS AND ANALYSIS
AGE DISTRIBUTION
Age in  years Nulli Nulli % Multi Multi %
<21 yrs 150 23.7 9 3.9
21-25 yrs 405 61.4 122 53.5
26-30 yrs 96 14.5 85 37.2
31-35 yrs 8 1.2 10 4.3
>35 yrs 0 0 2 0.8
Maximum  number  of   patients   are  in the  age  group  21 -25.Only  0.8%  of 
multipara  were  above  the age group of 35 years
                      
GESTATIONAL AGE IN WEEKS
Gestational 
age
Nullipara Nullipara% Multipara Multipara%
37-40 weeks 314 47.6 96 42.1
41 weeks 237 35.8 94 46.9
42 weeks 110 16 37 10.9
In nullipara, about 47.6% were induced prior to EDD. But in multipara,47% of  the 
patients were induced  post EDD.
                         BMI   AND MODE OF  DELIVERY
BMI Nulli NVD Nulli 
NVD %
Multi NVD Multi 
NVD%
<19.8 40 25 62.5 15 13 86.6
19.8-26 397 179 45.1 127 106 83.3
26-29 124 41 33.06 45 37 82.2
>29 98 23 23.5 41 28 68.2
Major group of the patients have BMI of  19.8-26.
As  BMI  of the patient increases,  there  is  proportionate  increase  in   the  operative 
delivery  especially  in  nulliipara .
ANTENATAL RISK FACTORS
RISK  FACTORS Nulli Nulli % Multi Multi %
Preeclampsia 192 55.97 63 60
Rh-ve pregnancy 48 13.9 13 12.38
IUGR/OLIGO 35 10.2 10 9.52
Long period of 
infertility
23 6.7 0 0
HEARTDISEASE 9 2.62 3 2.85
OTHERS 36 10.61 16 15.25
TOTAL                    343                 51.8                 105                   47.5
More than 50%   of the patients had an associated risk factor. 
Most common antenatal risk factor   found in  our  group  of patients  is   preeclampsia 
                             INDICATION FOR INDUCTION
Indication Nullipara Nulli% Multipara Multi %
Postdated 270 40.06 111 48.6
Preeclampsia 170 25.57 48 21.05
PROM 137 20.09 46 20.07
IUGR/OLIGO 41 6.68 6 2.91
Gestational 1 0.16 3 1.09
diabetes
Rh-ve 11 1.79 2 0.72
Severe 
preeclampsia
5 0.81 1 0.36
Fetal alarm 
signal
5 0.65 4 1.45
Imminent 
eclampsia
3 0.48 3 1.09
HROM 2 0.32 0 0
Postdated  pregnancy    was  the  major  cause  for  induction followed by preeclamptic 
toxemia followed by prelabour rupture of membranes.
              
MODE OF INDUCTION
Mode Nulli Nulli % Multi Multi %
PGE2 
SINGLE 
DOSE
382 57.8 152 66.6
PGE2 2 
DOSES
106 16.07 13 5.7
OXYTOCIN 171 25.94 58 25.43
In  all  patients  in the PGE2  group, oxytocin  used  in  the  augmentation of  labour. In 
patients  with  prelabour  rupture of  membranes, only  oxytocin  drip  used .   
                     
NORMAL VAGINAL DELIVERY IN VARIOUS MODES OF 
INDUCTION
Mode of 
induction
Nulli NVD Nulli 
NVD%
Multi NVD% Multi 
NVD%
PGE2 
SINGLE 
DOSE
382 158 41.3 152 128 84.2
PGE2 2 
DOSES
106 34 32 13 6 46.1
OXYTOCIN 171 70 40 58 46 86.6
About 41 .3% of patients induced with PGE2 delivered vaginally. The  high  LSCS  rate 
is because  more than  70%  of  patients had  associated medical  disorder ,which  had an 
influence on the decision along with no improvement  in mean  Bishop score.
INDICATION FOR LSCS
  
Indication Nulli Nulli % Multi Multi %
Failed 
induction 
112 19.5 21 9.40
Fetal distress 161 27 30 13.20
Cephalopelvic
disproportion
93 14.80 12 5.30
Others 21 3.10 8 3.50
  
.
                 Most common indication for LSCS is fetal distress in both primipara and 
multipara.  Failed  induction    accounts  for  20% of  LSCS in  primipara  and  10% of 
multipara.
                       
BIRTH WEIGHT
Birth weight Nulli Nulli % Multi Multi %
<2.5 kg 65 9.86 24 10.5
2.5-3.5 kg 560 83.7 221 96.92
3.6-4.0 kg 33 4.93 15 6.57
>4.0 kg 0 0 0 0
More than 90% of babies delivered weighed between 2.5- 3.5 kg. About 10% of babies 
weighed less than 2.5 kg.
       
                       RISK FACTORS AND MODE OF DELIVERY 
NVD NVD % LSCS LSCS%
Nulli  with 
risk factor
105 31.16 179 68.9
Nulli with no 
risk factor
166 51.5 155 48.4
Multi  with 
risk factor
82 76.6 100 23.3
Multi with no 
risk factor
25 84 19 15.9
As  more than  half of the  patients had an associated  medical  complication, it  accounts 
for  the  high  caesarean  rate   among  the  induced group with  associated  risk factors.
                                        
INTRAPARTUM   AND POSTPARTUM
COMPLICATIONS
Complication Nullipara Nulli % Multipara Multi %
Fever 27 4.08 9 3.9
Wound 
resuturing
12 1.81 1 0.36
Wound 
infection
13 1.9 0 0
Atonic PPH 5 0.89 3 1.09
Traumatic 
PPH
1 0.16 0 0
CPT 1 0.16 1 0.36
Rupture 
uterus
0 0 0 0
Apgar <7 60 9.78 10 3.64
MSL 54 8.8 13 4.7
Anaemia 1 0.16 1 0.36
Neonatal 
death
10 1.51 2 0.8
The most common complication was the febrile morbidity of the patients. Atonic PPH 
was seen  in  about  1% of  multipara.  Among them one  required  Internal  iliac  artery 
ligation to arrest haemorrhage.About 10% of babies delivered had Apgar <7.
.  
         INCIDENCE OF MSL AND HYPERBILIRUBINEMIA
MS
L
MSL 
%
HYPERBILIRUBINEM
IA
HYPERBILIRUBINEM
IA %
PGE2 
single 
dose 48
12.50
% 7 1.80%
PGE2 
two 
doses 14
13.20
% 3 2.80%
oxytoci
n 12 4.16 3
2.80
                                      
In the present  study, when two doses  of PGE2 was used, there was 
increased rate of meconium stained liquor and hyperbilirubinemia.
                        DISCUSSION
RATE OF INDUCTION
Total no of deliveries: 8386
No of term deliveries: 5973
No of induced term pregnancies with Bishop Score<4:887
CHARACTERISTICS OF THE PATIENT
Low dose 
oxytocin
High dose 
oxytocin present study
AGE 26.1 26 23.3
GA 38.1 38.1 41
NULLIPARA 216(52.4%) 207(51.4%) 659(74.2%)
BS<4 133(40.8%) 145(44.5%) ALL
Mean    Age     in the present study is 23.3 years. 
More than  two thirds  of  the  study  group  are  nullipara with mean  BISHOP SCORE 
<4  as against the study by MERILL et al   
                      INDICATION FOR INDUCTION
JARVELIN et al MERRILL et al PRESENT study
ELECTIVE 51.30% 12% NIL
PROM 2.30% 25.10% 21.60%
IUGR 5.20% 18% 4.79%
MEDICAL 
DISORDER 18.20% 13.30% 26.14%
POSTDATED 
PREGNANCY 12.30% 8% 44.70%
Medical  disorders  complicating    pregnancy forms  the major  cause  for  induction of 
labour  and  this  institution being a tertiary care  institution  with   referral  services  has 
large  group  of high  risk  patients.
COMPARING EFFICACY OF PGE2 SINGLE DOSE AND PGE2 
TWO DOSES
                                            
                                  NULLIPARA
PGE2 single dose PGE2 2 doses
MAC 
KENZIE et 
al
Present 
study
MAC 
KENZIE et 
al
Present 
study
No 237 382 262 106
NVD 128(54%) 15(40%) 143(55%) 34(32%)
INSRUMENTAL 
DELIVERY 74(31%) 13(3.5%) 84(34%) NIL
FAILED 
INDUCTION 4(2%) 46(12.4%) 3(1%) 48(46.3%)
FETAL 
DISTRESS 10(4%) 107(28.1%) 16(6%) 18(16.9%)
                         
                                         
                                              MULTIPARA
PGE2 single dose PGE2 2 doses
MAC 
KENZIE et 
al
Present 
study
MAC 
KENZIE et 
al
Present 
study
No 246 152 210 13
NVD 228(93%) 128(83.8%) 203(97%) 5(46.2%)
INSTRUMENTAL 
DELIVERY 14(6%) 0 0 0
FAILED 
INDUCTION 0 7(4.8%) 0 6(42.8%)
FETAL 
DISTRESS 1(0.4%) 10(6.6%) 1(0.5%) 2(14.2%)
Application  of second  dose  of  PGE2  did  not  improve  rate  of  vaginal   delivery.
According to MACKENZIE et al  in  his   RCT  comparing  1 dose Vs  2  dose 
,the  second  dose   resulted  in  more   prolonged   disturbance   with   little  benefit  in 
decreasing the need for  oxytocin  and labour  duration. Little  benefit  in inducing  with 
two  doses  as failed induction rate with 2 DOSES of PGE2 is  still around 48%  and 
comparable  with MACKENZIE et al.
SUCCESSFUL LABOUR OUTCOME WITH PGE2 ALONE
NIMROD et al PRESENT study
PGE2 9(60%) 288(32.4%)
Mean BishopScore 2.6 1.6
BS CHANGE<2 2(16%) 39(13.5%)
Rate of  failed  induction  was  16%    comparable  to  our  rate  of  13.5%.Improvement 
in  Bishop score by 3.86 in patients who delivered by single  dose of PGE2. While 
women  induced  with two  doses of PGE2  the  improvement  in  BS  was 1.65  after I 
gel  and  2.1  with  second  gel.
INDICATION FOR LSCS
INDICATION 
FOR  LSCS
                 MERILL    et al
Low dose               High  dose 
oxytocin                             oxytocin Present study
FAILED 
INDUCTION 25(6%) 25(5%) 119(29.3%)
FETAL 
DISTRESS 20(5%) 17(4%) 167(41.2%)
FAILURE  TO 
PROGRESS 20(5%) 17(4%) 91(22.40%)
OTHERS 3(0.7%) 3(0.7%) 28(6.9%)
The  higher rate  of  Caesarean  section  is because  the  74.8 % of patients included in 
the  present study are  nullipara  while  nullipara accounted  for only  52.4%  of patients 
in the study by  MERRILL et al. Moreover only 42% of patients had Bishop Score <4 
while all patients included in the present study had Bishop Score<4.
        INDUCTION – DELIVERY INTERVAL(IDI)
Average       
   IDI
In hours
Merrill et al            Present    study
Low dose 
oxytocin
High dose 
oxytocin
nullipara multipara
10.5 9.7 12.49 9.46
Parity  and  initial  bishop  score  influence  the  outcome  of  induced  labour.  The 
Induction delivery interval   is less in multipara compared to primipara.
INTRAPARTUM AND POSTPARTUM COMPLICATION
COMPLICATION low dose 
oxytocin
high dose 
oxytocin
Present study
UTERINE 
RUPTURE 1(0.2%) 1(0.2%) nil
PPH 19(4.9%) 15(4%) 9(1.1%)
WOUND 
INFECTION 2(0.5%) 1(0.3%)
19(2.47%)
Nil  rupture  rate  in  the  study  due  to  exclusion  of  previous  LSCS  and  non use  of 
epidural  analgesia.
NEONATAL COMPLICATIONS
COMPLICATION MERILL et al
low dose 
oxytocin high dose
present study
neonatal death 5(1.2) 4(1.1) 12(1.3)
Birth weight 3124 3174 2890
apgar<7 22(5.3) 22(5.8) 70(7.89)
SUMMARY
   
  
   Mean age of women 23.3with range between 18 and 37 years.
   Mean gestational age is 41 weeks.
   Nulliparous women accounted for 74.25%
   About 52% of primipara and 47.5% of multi has associated antepartum          
   risk factor.
   Medical disorders, mainly PET (23.41%) formed the major antenatal risk 
   factor.
   Most common indication for induction is postdatism followed by 
    Preeclampsia.
   Rate of vaginal delivery is   51.1% .Among them
   65.6% delivered   with single dose of PGE2 and augmentation with    
    oxytocin.
   8.59%    delivered   with two doses of PGE2and   augmentation with   
   oxytocin.
   Rate of caesarean section is 48.3%
   Common indication for induction is fetal distress.
   Mean birth weight is 2.89 with range between 1.5 and 4.0kg.
   No uterine rupture was encountered in the study.
                              CONCLUSION
The rate of induction of labour has increased nowadays with better methods for 
induction of labour and better techniques for evaluation of fetal wellbeing available. 
Clearly the favorability of the cervix has a substantial impact on the potential success of 
any labour  induction.  The  present  study thus  shows that  application  of  intracervical 
PGE2 gel caused favourable changes in the cervix by increasing the Bishop score with 
minimal side effects. Although labour induction is not without its risks for the mother 
and particularly for the fetus, intracervical PGE2 gel application followed by oxytocin is 
found  to  be  safe  and  acceptable  method  for  induction  of  labour  in  patients  with 
unfavourable cervix with minimal maternal morbidity and mortality.
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                         PROFORMA
                                                                                                                UNIT
NAME    :
AGE              :                                                 IPNO
DOA                                              :                              BOOKED/IMMUNISED
OBSTETRIC CODE                                      :
LMP                                               :
EDD     :
CYCLES                                             :
PREVIOUS PREGNANCY OUTCOME        :
ASSOCIATED PREGNANCY COMPLICATION:
            Maternal:
            Fetal:
ON EXAMINATION
Pallor:          Height
Febrile Weight
Jaundiced                                                                     Pulse rate:
Pedal edema              Blood pressure:
                                         CVS
                                          RS
Per Abdomen Examination:
          Uterus
Acting /Not acting
Engagement
FHR
Liquor
Per Vaginal Examination
Cervix effacement
                                  Position
   Dilatation
                                  Membranes Bishop Score:
   Vertex
   Pelvis
                                 Liquor
INVESTIGATION:
Haemoglobin:
Urine
Blood Group 
Ultrasonogram:
AFI:
Cardiotocogram:
Reason for Induction:
Mode of Induction:
Time of Induction:    Time          6hr            12hr          18hr                 24hr
Bishop score:
Side Effects:
                 Maternal: Fetal:
Mode of Delivery:
NVD/Forceps/Ventouse/LSCS                           Induction – Delivery Interval
                                         Indication :
Time:
Baby sex:
Weight:
Apgar:
Admitted/Not Admitted: Cause:
Complication:
Intrapartum:
Postpartum:
          Neonatal:
 
                                                              GLOSSARY
IOL         -             Induction of Labour
CTG        -             Cardiotocogram
FHR        -            Fetal heart rate
PET         -            Preeclamptic toxemia
AFI         -            Amniotic fluid index
PPH        -             Postpartum haemorrhage
APH       -             Antepartum haemorrhage
CPT        -             Complete perineal tear
IUGR      -            Intrauterine growth restriction
MSL      -            Meconium stained liquor
NVD      -            Normal vaginal delivery
NICU     -            Neonatal intensive care unit
BS         -            Bishop score
